Form D — Rapalogix Health, Inc.
0002008372-25-000002 · filed Jun 4, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $13,500,000
- Total sold
- $9,079,616
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rapalogix Health, Inc.
- CIK
- 2008372
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 3129 TIGER RUN COURT
CARLSBAD, CA 92010 - Phone
- (760) 707-2412
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Rahul Mehta · Executive OfficerNew York, NY Find on LinkedIn ↗
-
James Peyer · DirectorNew York, NY Find on LinkedIn ↗
-
Juliette Han · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Joan Mannick · DirectorNew York, NY Find on LinkedIn ↗
-
Brent Saunders · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Doris Day · DirectorNew York, NY Find on LinkedIn ↗
-
David Nicholson · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗